• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2021年全球、区域和国家哮喘负担及到2050年的发病率预测:全球疾病负担研究2021的系统分析

Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021.

作者信息

Yuan Linna, Tao Junxian, Wang Jiacheng, She Wei, Zou Yuping, Li Ruilin, Ma Yingnan, Sun Chen, Bi Shuo, Wei Siyu, Chen Haiyan, Guo Xuying, Tian Hongsheng, Xu Jing, Dong Yu, Ma Ye, Sun Hongmei, Lv Wenhua, Shang Zhenwei, Jiang Yongshuai, Lv Hongchao, Zhang Mingming

机构信息

College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.

出版信息

EClinicalMedicine. 2025 Jan 9;80:103051. doi: 10.1016/j.eclinm.2024.103051. eCollection 2025 Feb.

DOI:10.1016/j.eclinm.2024.103051
PMID:39867965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11764843/
Abstract

BACKGROUND

Asthma is the second leading cause of mortality among chronic respiratory illnesses. This study provided a comprehensive analysis of the burden of asthma.

METHODS

Data on asthma were extracted from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. We focused on the effects of age, sex, risk factors, and the socio-demographic index (SDI) on the burden of asthma and calculated the average annual percent change (AAPC) via joinpoint regression. Two-sample Mendelian randomization (MR) was adopted to estimate the causal relationships between risk factors and asthma. The Bayesian age-period-cohort (BAPC) model was used to predict incidence patterns of asthma from 2022 to 2050.

FINDINGS

In 2021, there was an observed prevalence of asthma, with 3,340 cases per 100,000 people. Males who were below 20 years old had a greater prevalence of asthma. The incidence and prevalence correlated positively with the SDI, whereas mortality and disability-adjusted life years (DALYs) correlated negatively. The contribution of high body mass index (BMI) to asthma DALYs increased by 4.3% worldwide between 1990 and 2021. MR studies have confirmed that high BMI and smoking can increase the risk of asthma. The prediction results indicated that the global age-standardised incidence rate will remain high from 2022 to 2050.

INTERPRETATION

The global mortality of patients with asthma is a significant concern. The analysis of the burden of asthma can help formulate public health policies, allocate resources, and prevent asthma.

FUNDING

This study was supported by the National Natural Science Foundation of China; Program for Young Talents of Basic Research in Universities of Heilongjiang Province; Marshal Initiative Funding; Mathematical Tianyuan Fund of the National Natural Science Foundation of China; XingLian Outstanding Talent Support Program 2024.

摘要

背景

哮喘是慢性呼吸道疾病中第二大致死原因。本研究对哮喘负担进行了全面分析。

方法

从《2021年全球疾病、伤害及风险因素负担研究》(GBD 2021)中提取哮喘相关数据。我们重点关注年龄、性别、风险因素和社会人口学指数(SDI)对哮喘负担的影响,并通过连接点回归计算平均年度百分比变化(AAPC)。采用两样本孟德尔随机化(MR)方法估计风险因素与哮喘之间的因果关系。使用贝叶斯年龄-时期-队列(BAPC)模型预测2022年至2050年哮喘的发病模式。

研究结果

2021年,观察到哮喘患病率为每10万人中有3340例。20岁以下男性哮喘患病率更高。发病率和患病率与SDI呈正相关,而死亡率和伤残调整生命年(DALY)呈负相关。1990年至2021年期间,全球高体重指数(BMI)对哮喘DALY的贡献增加了4.3%。MR研究证实,高BMI和吸烟会增加患哮喘的风险。预测结果表明,2022年至2050年全球年龄标准化发病率将居高不下。

解读

哮喘患者的全球死亡率是一个重大问题。对哮喘负担的分析有助于制定公共卫生政策、分配资源和预防哮喘。

资金来源

本研究得到中国国家自然科学基金;黑龙江省高校基础研究青年人才项目;元帅计划资助;中国国家自然科学基金数学天元基金;2024年兴联优秀人才支持计划的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/8257b7108e52/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/8684dc0fa150/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/2e5cd105813e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/ec1712692743/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/ac5cc5aaf9d1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/6b8bc328d560/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/bee067b50696/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/8257b7108e52/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/8684dc0fa150/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/2e5cd105813e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/ec1712692743/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/ac5cc5aaf9d1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/6b8bc328d560/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/bee067b50696/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71c9/11764843/8257b7108e52/gr7.jpg

相似文献

1
Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021.1990年至2021年全球、区域和国家哮喘负担及到2050年的发病率预测:全球疾病负担研究2021的系统分析
EClinicalMedicine. 2025 Jan 9;80:103051. doi: 10.1016/j.eclinm.2024.103051. eCollection 2025 Feb.
2
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.全球、地区和国家慢性阻塞性肺疾病和哮喘的死亡、患病率、残疾调整生命年以及与残疾相关的生命年,1990-2015 年:2015 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16.
3
Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.1990 - 2021年全球、区域和国家哮喘及特应性皮炎负担以及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Respir Med. 2025 May;13(5):425-446. doi: 10.1016/S2213-2600(25)00003-7. Epub 2025 Mar 24.
4
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家 84 种行为、环境、职业和代谢风险以及 195 个国家和地区 1990 至 2017 年风险簇的比较风险评估:全球疾病负担研究 2017 系统分析。
Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8.
5
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.全球、地区和国家 1990 年至 2021 年糖尿病负担,以及对 2050 年患病率的预测:2021 年全球疾病负担研究的系统分析。
Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22.
6
Causal impact of elevated body mass index on diabetic kidney disease: an integrated Mendelian randomization and Global Burden of Disease Study 2021 analysis.体重指数升高对糖尿病肾病的因果影响:孟德尔随机化与2021年全球疾病负担研究的综合分析
Ren Fail. 2025 Dec;47(1):2472981. doi: 10.1080/0886022X.2025.2472981. Epub 2025 Mar 17.
7
Global, regional, and national burden of kidney cancer and attributable risk factors in adults aged 65 years and older from 1990 to 2021 and projections to 2040.1990年至2021年以及至2040年预测期间65岁及以上成年人肾癌的全球、区域和国家负担及可归因风险因素
BMC Cancer. 2025 Mar 15;25(1):481. doi: 10.1186/s12885-025-13902-w.
8
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年食管痛的全球、区域和国家负担及其可归因风险因素:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582-597. doi: 10.1016/S2468-1253(20)30007-8. Epub 2020 Apr 1.
9
Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021.1990年至2021年全球、区域和国家类风湿关节炎负担及到2050年的发病率预测:对《2021年全球疾病负担研究》的系统全面分析
Biomark Res. 2025 Mar 24;13(1):47. doi: 10.1186/s40364-025-00760-8.
10
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.全球、地区和国家的过敏疾病负担及其风险因素:2019 年全球疾病负担研究 1990-2019 年系统性分析。
Allergy. 2023 Aug;78(8):2232-2254. doi: 10.1111/all.15807. Epub 2023 Jul 11.

引用本文的文献

1
Why Every Asthma Patient Tells a Different Story.为何每位哮喘患者的情况各不相同。
J Clin Med. 2025 Aug 9;14(16):5641. doi: 10.3390/jcm14165641.
2
Unmasking Pediatric Asthma: Epigenetic Fingerprints and Markers of Respiratory Infections.揭开儿童哮喘的面纱:表观遗传指纹与呼吸道感染标志物
Int J Mol Sci. 2025 Aug 6;26(15):7629. doi: 10.3390/ijms26157629.
3
Sociodemographic predictors of digital health adoption in patients with asthma and COPD.哮喘和慢性阻塞性肺疾病患者采用数字健康的社会人口学预测因素。

本文引用的文献

1
The Lifelong Burden of Severe Childhood Asthma.儿童重症哮喘的终身负担
Chest. 2024 Oct;166(4):653-654. doi: 10.1016/j.chest.2024.07.137.
2
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
3
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Front Digit Health. 2025 Jul 28;7:1579983. doi: 10.3389/fdgth.2025.1579983. eCollection 2025.
4
Global, regional, and national burden of colorectal cancer in the elderly (aged > 60 years): a comprehensive analysis across 204 countries and territories (1990-2021)​.老年人(年龄>60岁)结直肠癌的全球、区域和国家负担:对204个国家和地区(1990-2021年)的综合分析
BMC Gastroenterol. 2025 Aug 9;25(1):570. doi: 10.1186/s12876-025-04184-4.
5
Too Much SAMA, Too Many Exacerbations: A Call for Caution in Asthma.过多的短效抗胆碱能药物,过多的急性加重:哮喘治疗需谨慎呼吁
J Clin Med. 2025 Jul 16;14(14):5046. doi: 10.3390/jcm14145046.
6
Global, regional and national burden of asthma from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家哮喘负担:全球疾病负担研究2021的系统分析
BMJ Open Respir Res. 2025 Jul 23;12(1):e003144. doi: 10.1136/bmjresp-2025-003144.
7
Neutrophil-to-lymphocyte ratio as a biomarker for asthma identification and severity stratification: a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值作为哮喘识别和严重程度分层的生物标志物:一项系统评价和荟萃分析
Front Med (Lausanne). 2025 Jun 24;12:1620695. doi: 10.3389/fmed.2025.1620695. eCollection 2025.
8
Global, regional, and national burden of chronic respiratory diseases,1990-2021 and predictions to 2035: analysis of data from the global burden of disease study 2021.1990年至2021年全球、区域和国家慢性呼吸道疾病负担及到2035年的预测:全球疾病负担研究2021数据分析
Ann Med. 2025 Dec;57(1):2530225. doi: 10.1080/07853890.2025.2530225. Epub 2025 Jul 8.
9
Identification of components in scorpion and centipede traditional Chinese medicine formulations with potentially beneficial actions in asthma: network pharmacology and molecular docking.鉴定蝎子和蜈蚣中药配方中对哮喘可能具有有益作用的成分:网络药理学与分子对接
Hereditas. 2025 Jul 2;162(1):120. doi: 10.1186/s41065-025-00490-9.
10
Microfungus and the Fungus-like Organism as Potential Inhalant Allergens in a Mouse Model of Asthma.作为哮喘小鼠模型中潜在吸入性过敏原的微真菌和类真菌生物
Cells. 2025 Jun 17;14(12):914. doi: 10.3390/cells14120914.
全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
4
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.婴幼儿呼吸道合胞病毒感染的短期和中期发病率及初级保健负担:一项西班牙六年基于人群的纵向研究。
Pediatr Allergy Immunol. 2024 May;35(5):e14131. doi: 10.1111/pai.14131.
5
Risk factors for asthma-related hospital and intensive care admissions in children, adolescents and adults: a cohort study using primary and secondary care data.哮喘相关住院和重症监护入院的风险因素:一项利用初级和二级医疗数据的队列研究。
BMJ Open Respir Res. 2024 May 1;11(1):e001746. doi: 10.1136/bmjresp-2023-001746.
6
Climate change and its impact on asthma.气候变化及其对哮喘的影响。
Nurse Pract. 2024 May 1;49(5):25-32. doi: 10.1097/01.NPR.0000000000000174.
7
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
8
Early life exposure to pollens and increased risks of childhood asthma: a prospective cohort study in Ontario children.花粉暴露与儿童哮喘风险增加:安大略省儿童的前瞻性队列研究。
Eur Respir J. 2024 Apr 18;63(4). doi: 10.1183/13993003.01568-2023. Print 2024 Apr.
9
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
10
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.